Table 2 Pharmacologic treatment of the study cohort at baseline
All 289 | Men 158 (54.7%) | Women 131 (45.3%) | p value | |
|---|---|---|---|---|
No treatment (n; %) | 155; 53.6 | 81; 51.3 | 74; 56.5 | ns |
Metformin (n; %) | 84; 29.1 | 48; 30.4 | 36; 27.5 | ns |
Secretagogues (± metformin; n; %) | 50; 17.3 | 29; 18.4 | 21; 16.0 | ns |
Anti-hypertensive treatment (n; %) | 179; 61.9 | 103; 65.2 | 76; 58.0 | ns |
Statins (n; %) | 88; 30.4 | 50; 31.6 | 38; 29.0 | ns |